(VIANEWS) – Shares of Inovio Pharmaceuticals (NASDAQ: INO) dropped by a staggering 15.71% in 5 sessions from $1.91 at -15.71, to $1.61 at 19:27 EST on Thursday, after two successive sessions in a row of losses. NASDAQ is dropping 1.02% to $11,789.58, after two consecutive sessions in a row of losses. Inovio Pharmaceuticals’s last close…
(VIANEWS) – Shares of Inovio Pharmaceuticals (NASDAQ: INO) dropped by a staggering 10.22% to $1.67 at 16:14 EST on Wednesday, following the last session’s upward trend. NASDAQ is falling 1.81% to $11,894.40, following the last session’s upward trend. This seems, so far, an all-around down trend trading session today. Inovio Pharmaceuticals’s last close was $1.86,…
(VIANEWS) – Shares of Inovio Pharmaceuticals (NASDAQ: INO) jumped by a staggering 17.18% in 5 sessions from $1.63 at 17.18, to $1.91 at 19:27 EST on Sunday, after four successive sessions in a row of gains. NASDAQ is falling 1.59% to $12,006.96, following the last session’s downward trend. Inovio Pharmaceuticals’s last close was $1.91, 55.37%…
(VIANEWS) – Shares of Inovio Pharmaceuticals (NASDAQ: INO) rose by a staggering 17.18% in 5 sessions from $1.63 at 17.18, to $1.91 at 19:33 EST on Friday, after four sequential sessions in a row of gains. NASDAQ is sliding 1.59% to $12,006.96, following the last session’s downward trend. Inovio Pharmaceuticals’s last close was $1.91, 55.37%…
(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are Unifi New, Clorox Company, and Veritiv Corporation. Rank Financial Asset Price Change Updated (EST) 1 Unifi New (UFI) 9.90 12.24% 2023-02-03 09:23:15 2 Clorox Company…
(VIANEWS) – Shares of Inovio Pharmaceuticals (NASDAQ: INO) jumped 9.28% to $1.83 at 13:27 EST on Thursday, after two successive sessions in a row of gains. NASDAQ is rising 3.17% to $12,190.91, after two successive sessions in a row of gains. This seems, at the moment, a very bullish trend exchanging session today. Inovio Pharmaceuticals’s…
